Cartesian Therapeutics, Inc. Repayments of Long-Term Debt
Cartesian Therapeutics, Inc. (RNAC) reported Repayments of Long-Term Debt of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2025-03-13
- Cartesian Therapeutics, Inc. repayments of long-term debt for the quarter ending 2024-12-31 was $0.00.
- Cartesian Therapeutics, Inc. repayments of long-term debt for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Cartesian Therapeutics, Inc. repayments of long-term debt for the quarter ending 2023-12-31 was $0.00.
- Cartesian Therapeutics, Inc. repayments of long-term debt for the quarter ending 2023-09-30 was $24.87M.
- Cartesian Therapeutics, Inc. repayments of long-term debt for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Cartesian Therapeutics, Inc. repayments of long-term debt for fiscal 2023 was $27.46M.
- Cartesian Therapeutics, Inc. repayments of long-term debt for fiscal 2022 was $0.00.
- Cartesian Therapeutics, Inc. repayments of long-term debt for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $0.00 derived: sum of 2 quarters · filed 2025-03-13 | $0.00 10-K · filed 2025-03-13 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $24.87M derived: sum of 2 quarters · filed 2025-03-13 | $27.46M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $24.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $27.46M 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $2.59M 10-Q · filed 2024-08-08 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-03-07 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $0.00 derived: sum of 2 quarters · filed 2024-03-07 | $0.00 derived: sum of 3 quarters · filed 2024-03-07 | $0.00 10-K · filed 2024-03-07 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | $0.00 derived: sum of 3 quarters · filed 2023-03-02 | $15.11M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | $15.11M derived: sum of 3 quarters · filed 2023-03-02 | $17.21M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $15.11M derived: sum of 2 quarters · filed 2023-03-02 | $17.21M derived: sum of 3 quarters · filed 2023-03-02 | $19.31M 10-K · filed 2023-03-02 |
| 2020-09-30 | $15.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $17.21M derived: sum of 2 quarters · filed 2021-11-09 | $19.31M 10-Q · filed 2021-11-09 | $21.41M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $4.20M 10-Q · filed 2021-08-12 | $6.30M derived: sum of 3 quarters · filed 2022-03-10 | $7.00M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | $2.10M 10-Q · filed 2021-05-13 | $4.20M derived: sum of 2 quarters · filed 2022-03-10 | $4.90M derived: sum of 3 quarters · filed 2022-03-10 | $4.90M derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $2.80M derived: sum of 2 quarters · filed 2022-03-10 | $2.80M derived: sum of 3 quarters · filed 2022-03-10 | $2.80M 10-K · filed 2022-03-10 |
| 2019-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $700.00K derived: sum of 2 quarters · filed 2020-11-05 | $700.00K 10-Q · filed 2020-11-05 | $700.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | $0.00 derived: sum of 3 quarters · filed 2021-03-12 | $0.00 derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | $0.00 derived: sum of 2 quarters · filed 2021-03-12 | $0.00 derived: sum of 3 quarters · filed 2021-03-12 | $0.00 derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $0.00 derived: sum of 2 quarters · filed 2021-03-12 | $0.00 derived: sum of 3 quarters · filed 2021-03-12 | $0.00 10-K · filed 2021-03-12 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $0.00 derived: sum of 2 quarters · filed 2019-11-08 | $0.00 10-Q · filed 2019-11-08 | $0.00 derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $0.00 10-Q · filed 2018-08-08 | $0.00 derived: sum of 3 quarters · filed 2020-03-12 | $11.10M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 | $0.00 derived: sum of 2 quarters · filed 2020-03-12 | $11.10M derived: sum of 3 quarters · filed 2020-03-12 | $12.21M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $11.10M derived: sum of 2 quarters · filed 2020-03-12 | $12.21M derived: sum of 3 quarters · filed 2020-03-12 | $12.93M 10-K · filed 2020-03-12 |
| 2017-09-30 | $11.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $12.21M derived: sum of 2 quarters · filed 2018-11-08 | $12.93M 10-Q · filed 2018-11-08 | $12.93M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $1.84M 10-Q · filed 2018-08-08 | $1.84M derived: sum of 3 quarters · filed 2019-03-15 | $1.84M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $728.00K 10-Q · filed 2018-05-09 | $728.00K derived: sum of 2 quarters · filed 2019-03-15 | $728.00K derived: sum of 3 quarters · filed 2019-03-15 | $728.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $0.00 derived: sum of 2 quarters · filed 2019-03-15 | $0.00 derived: sum of 3 quarters · filed 2019-03-15 | $0.00 10-K · filed 2019-03-15 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | $717.00K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $0.00 10-Q · filed 2017-08-11 | $717.00K derived: sum of 3 quarters · filed 2018-03-15 | $1.42M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-11 | $717.00K derived: sum of 2 quarters · filed 2018-03-15 | $1.42M derived: sum of 3 quarters · filed 2018-03-15 | |
| 2015-12-31 | $717.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $1.42M derived: sum of 2 quarters · filed 2018-03-15 | $2.34M 10-K · filed 2018-03-15 | |
| 2015-09-30 | $703.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $1.62M 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $916.00K 10-Q · filed 2016-08-09 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |